AI Tool Helps Detect Early-Stage Breast Cancers in NHS Trial, Spotting Tumors Doctors Missed
-
A medical AI called Mia, developed by Kheiron Medical Technologies, helped identify signs of breast cancer in 11 women that doctors had missed in an NHS trial covering 10,889 patients.
-
Mia was used by NHS Grampian health authority in Scotland, with data analyzed via Microsoft's Azure cloud network. The tool allowed doctors to find 12% more cancers than typically expected.
-
Mia appeared faster than humans and picked up on cancer signs that even highly-trained professionals missed, spotting tumors too tiny for radiologists to notice.
-
One 6mm tumor found by Mia only required minimal surgery and 5 days of radiotherapy for the patient, Barbara. Cancers under 15mm have a 95% survival rate.
-
The trial was funded by the UK government and caught the attention of senior ministers. Finance minister Jeremy Hunt wrote that innovations like Mia can drive huge improvements in productivity in public services.